Announcement • Jun 23
Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering in the amount of $1.678301 million. Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering in the amount of $1.678301 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Transaction Features: At the Market Offering Reported Earnings • May 13
First quarter 2026 earnings released: EPS: US$0.003 (vs US$0.02 loss in 1Q 2025) First quarter 2026 results: EPS: US$0.003 (up from US$0.02 loss in 1Q 2025). Revenue: US$623.0k (down 10.0% from 1Q 2025). Net income: US$22.0k (up US$161.0k from 1Q 2025). Profit margin: 3.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Announcement • May 05
Oxbridge Re Holdings Limited to Report Q1, 2026 Results on May 11, 2026 Oxbridge Re Holdings Limited announced that they will report Q1, 2026 results After-Market on May 11, 2026 Announcement • Apr 30
Oxbridge Re Holdings Limited, Annual General Meeting, Jun 12, 2026 Oxbridge Re Holdings Limited, Annual General Meeting, Jun 12, 2026. Location: suite 201, 42 edward street, george town, Cayman Islands Reported Earnings • Mar 31
Full year 2025 earnings released: US$0.28 loss per share (vs US$0.45 loss in FY 2024) Full year 2025 results: US$0.28 loss per share (improved from US$0.45 loss in FY 2024). Revenue: US$2.58m (up 372% from FY 2024). Net loss: US$2.08m (loss narrowed 24% from FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. New Risk • Mar 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Market cap is less than US$10m (US$6.66m market cap). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (US$2.6m revenue). Announcement • Mar 21
Oxbridge Re Holdings Limited to Report Q4, 2025 Results on Mar 30, 2026 Oxbridge Re Holdings Limited announced that they will report Q4, 2025 results After-Market on Mar 30, 2026 Board Change • Feb 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Arun Gowda was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 07
Third quarter 2025 earnings released: US$0.024 loss per share (vs US$0.088 loss in 3Q 2024) Third quarter 2025 results: US$0.024 loss per share (improved from US$0.088 loss in 3Q 2024). Revenue: US$645.0k (up 215% from 3Q 2024). Net loss: US$187.0k (loss narrowed 65% from 3Q 2024). Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 11% per year. Announcement • Oct 28
Oxbridge Re Holdings Limited to Report Q3, 2025 Results on Nov 06, 2025 Oxbridge Re Holdings Limited announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 06, 2025 New Risk • Aug 31
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$53k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Significant insider selling over the past 3 months (US$53k sold). Revenue is less than US$5m (US$2.0m revenue). Market cap is less than US$100m (US$16.2m market cap). Reported Earnings • Aug 15
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: US$0.25 loss per share (further deteriorated from US$0.14 loss in 2Q 2024). Revenue: US$664.0k (up US$620.0k from 2Q 2024). Net loss: US$1.87m (loss widened 128% from 2Q 2024). Revenue missed analyst estimates by 40%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 54% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Announcement • Aug 05
Oxbridge Re Holdings Limited to Report Q2, 2025 Results on Aug 14, 2025 Oxbridge Re Holdings Limited announced that they will report Q2, 2025 results After-Market on Aug 14, 2025 Announcement • Jul 10
Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering. Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering.
Security Name: Common Stock
Security Type: Common Stock
Price\Range: $2.27
Transaction Features: At the Market Offering New Risk • Jul 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Revenue is less than US$5m (US$1.4m revenue). Market cap is less than US$100m (US$13.2m market cap). Recent Insider Transactions • May 20
Chairman recently bought US$53k worth of stock On the 15th of May, Sanjay Madhu bought around 25k shares on-market at roughly US$2.10 per share. This transaction amounted to 5.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Sanjay's only on-market trade for the last 12 months. Reported Earnings • May 14
First quarter 2025 earnings: EPS and revenues exceed analyst expectations First quarter 2025 results: US$0.02 loss per share (improved from US$0.15 loss in 1Q 2024). Net loss: US$139.0k (loss narrowed 85% from 1Q 2024). Revenue exceeded analyst estimates by 5.8%. Earnings per share (EPS) also surpassed analyst estimates by 33%. Revenue is forecast to grow 56% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance. Announcement • May 03
Oxbridge Re Holdings Limited to Report Q1, 2025 Results on May 12, 2025 Oxbridge Re Holdings Limited announced that they will report Q1, 2025 results at 4:00 PM, US Eastern Standard Time on May 12, 2025 New Risk • Apr 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.60m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 49% per year over the past 5 years. Revenue is less than US$1m (US$546k revenue). Market cap is less than US$10m (US$9.60m market cap). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Reported Earnings • Mar 27
Full year 2024 earnings released: US$0.45 loss per share (vs US$1.69 loss in FY 2023) Full year 2024 results: US$0.45 loss per share (improved from US$1.69 loss in FY 2023). Net loss: US$2.73m (loss narrowed 73% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance. Announcement • Mar 27
Oxbridge Re Holdings Limited, Annual General Meeting, May 08, 2025 Oxbridge Re Holdings Limited, Annual General Meeting, May 08, 2025. Location: at the companys office, suite 201, george town,42 edward street, Cayman Islands Announcement • Mar 06
Oxbridge Re Holdings Limited and Suranceplus Announces Two Rwa Tokenized Reinsurance Offerings for Its 2025 - 2026 Season: Targeting Returns of 20% and 42% Oxbridge Re Holdings Limited together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets ("RWAs"), initially with tokenized reinsurance securities, and in providing reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States, announced the launch of its 2025 tokenized reinsurance offerings. For the first time, investors can choose their preferred risk-return profile with two distinct options: EtaCat Re - 20% (Balanced Yield); ZetaCat Re - 42% (High Yield). These blockchain-powered offerings open access to an asset class that was previously exclusive to institutional investors and ultra-high-net-worth individuals. Now, a wider range of investors can access SurancePlus' tokenized reinsurance securities, targeting high-yield returns backed by Real-World Assets (RWAs) through real-world reinsurance contracts. Investors in EtaCat Re have a targeted annual return of 20%, while investors in ZetaCat Re have an annual targeted return of 42%. Each security-backed token is priced at $10 per share, with funds used to invest in reinsurance contracts. Investors will receive 3.5% APY on their invested funds until contracts go live on June 1, 2025. Results are then distributed annually based on underwriting performance. These tokens provide exposure to RWA-collateralized reinsurance contracts through its licensed Cayman Islands reinsurance entity, Oxbridge Re NS. Investment opportunities are available to U.S. investors under SEC Rule 506(c) and to non-U.S. investors under Regulation S of the Securities Act of 1933. Announcement • Feb 26
Oxbridge Re Holdings Limited has completed a Follow-on Equity Offering in the amount of $3.000007 million. Oxbridge Re Holdings Limited has completed a Follow-on Equity Offering in the amount of $3.000007 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 705,884
Price\Range: $4.25
Discount Per Security: $0.255
Transaction Features: Registered Direct Offering Announcement • Feb 25
Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering in the amount of $3.000007 million. Oxbridge Re Holdings Limited has filed a Follow-on Equity Offering in the amount of $3.000007 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 705,884
Price\Range: $4.25
Transaction Features: Registered Direct Offering Recent Insider Transactions Derivative • Feb 21
CFO, Secretary & Director exercised options and sold US$110k worth of stock On the 14th of February, Wrendon Timothy exercised 90.00k options at around US$2.00, then sold 35k of the shares acquired at an average of US$5.14 per share and kept the remainder. Since March 2024, Wrendon has owned 75.05k shares directly. Company insiders have collectively sold US$104k more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Nov 15
Third quarter 2024 earnings released: US$0.088 loss per share (vs US$1.24 loss in 3Q 2023) Third quarter 2024 results: US$0.088 loss per share (improved from US$1.24 loss in 3Q 2023). Net loss: US$540.0k (loss narrowed 93% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance. Announcement • Oct 31
Oxbridge Re Holdings Limited to Report Q3, 2024 Results on Nov 13, 2024 Oxbridge Re Holdings Limited announced that they will report Q3, 2024 results After-Market on Nov 13, 2024 Reported Earnings • Aug 09
Second quarter 2024 earnings released: US$0.14 loss per share (vs US$0.014 loss in 2Q 2023) Second quarter 2024 results: US$0.14 loss per share (further deteriorated from US$0.014 loss in 2Q 2023). Revenue: US$44.0k (down 94% from 2Q 2023). Net loss: US$821.0k (loss widened US$736.0k from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. New Risk • Aug 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.0m free cash flow). Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 7.8% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Significant insider selling over the past 3 months (US$61k sold). Market cap is less than US$100m (US$17.5m market cap). Announcement • Aug 02
Oxbridge Re Holdings Limited to Report Q2, 2024 Results on Aug 08, 2024 Oxbridge Re Holdings Limited announced that they will report Q2, 2024 results After-Market on Aug 08, 2024 New Risk • May 14
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.0m free cash flow). Earnings have declined by 7.8% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (US$7.93m market cap). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Reported Earnings • May 10
First quarter 2024 earnings released: US$0.15 loss per share (vs US$0.024 profit in 1Q 2023) First quarter 2024 results: US$0.15 loss per share (down from US$0.024 profit in 1Q 2023). Net loss: US$905.0k (down US$1.05m from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance. Announcement • May 03
Oxbridge Re Holdings Limited to Report Q1, 2024 Results on May 08, 2024 Oxbridge Re Holdings Limited announced that they will report Q1, 2024 results After-Market on May 08, 2024 Announcement • May 01
Oxbridge Re Holdings Limited, Annual General Meeting, Jun 14, 2024 Oxbridge Re Holdings Limited, Annual General Meeting, Jun 14, 2024, at 09:00 US Eastern Standard Time. Location: Suite 201, 42 Edward Street Geoge Town Cayman Islands Agenda: To consider and vote upon a proposal to elect five directors to serve on the Board of Directors of the Company until the Annual General Meeting of Shareholders of the Company in 2025; to consider and vote upon a proposal to ratify the appointment of Hacker, Johnson & Smith, P.A., as the independent auditors of the Company for the fiscal year ending December 31, 2024; and to transact such other business that may properly come before the meeting or any adjournments or postponements thereof. Reported Earnings • Mar 27
Full year 2023 earnings released: US$1.69 loss per share (vs US$0.31 loss in FY 2022) Full year 2023 results: US$1.69 loss per share (further deteriorated from US$0.31 loss in FY 2022). Net loss: US$9.92m (loss widened 454% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Announcement • Mar 08
Oxbridge Re Holdings Limited to Report Q4, 2023 Results on Mar 26, 2024 Oxbridge Re Holdings Limited announced that they will report Q4, 2023 results on Mar 26, 2024 Reported Earnings • Nov 16
Third quarter 2023 earnings released: US$1.24 loss per share (vs US$0.37 loss in 3Q 2022) Third quarter 2023 results: US$1.24 loss per share (further deteriorated from US$0.37 loss in 3Q 2022). Net loss: US$7.30m (loss widened 238% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Announcement • Nov 08
Oxbridge Re Holdings Limited to Report Q3, 2023 Results on Nov 14, 2023 Oxbridge Re Holdings Limited announced that they will report Q3, 2023 results After-Market on Nov 14, 2023 Recent Insider Transactions • Oct 04
Chairman recently bought US$60k worth of stock On the 29th of September, Sanjay Madhu bought around 50k shares on-market at roughly US$1.20 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Sanjay's only on-market trade for the last 12 months. Announcement • Aug 10
Oxbridge Re Holdings Limited to Report Q2, 2023 Results on Aug 14, 2023 Oxbridge Re Holdings Limited announced that they will report Q2, 2023 results After-Market on Aug 14, 2023 Announcement • May 09
Oxbridge Re Holdings Limited to Report Q1, 2023 Results on May 12, 2023 Oxbridge Re Holdings Limited announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 12, 2023 Reported Earnings • Apr 02
Full year 2022 earnings released: US$0.31 loss per share (vs US$1.49 profit in FY 2021) Full year 2022 results: US$0.31 loss per share (down from US$1.49 profit in FY 2021). Net loss: US$1.79m (down 121% from profit in FY 2021). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Board Change • Jan 20
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman, President & CEO Jay Madhu is the most experienced director on the board, commencing their role in 2013. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Announcement • Dec 21
Oxbridge Re Holdings Limited Appoints Reuel Ocho as Head of Special Projects Oxbridge Re Holdings Limited announced that Dr. Reuel Ocho has been appointed head of the company’s special projects division. A seasoned technology executive, Dr. Ocho has delivered strategic and executive IT-related services to a number of high-profile public, private and governmental organizations in Europe and the Caribbean over the past 19 years. Prior to joining Oxbridge, Dr. Ocho was the Chief Technology Officer for the Cayman Islands Ministry of Financial Services and Commerce. Dr. Ocho is a digital innovation, digital transformation and blockchain technology strategy subject matter expert with professional leadership and management experience delivering cutting-edge digital platforms, products, and strategic solutions for organizations in both regulated and non-regulated environments. He has extensive technical expertise and has experience formulating focused and detailed digital innovation strategies and corresponding implementation programs for organizations, delivering digital solutions, and managing high-performing multidisciplinary teams. He also holds expertise and experience in machine learning/artificial intelligence, IT strategy and operations, software development, solutions architecture, data architecture, enterprise architecture, enterprise agile methods and cloud technology. Dr. Ocho earned a Ph.D. in Information Systems from the London School of Economics (LSE), an MSc. in Advanced Software Engineering with Distinction from King's College London, and a BSc. in Computer Science from Andrews University. Announcement • Nov 19
Oxbridge Re Holdings Limited Announces Executive Changes On November 11, 2022, the Board of Directors of Oxbridge Re Holdings Limited accepted the resignation of Mr. Kris Persaud as an independent director of the Company, effective immediately. Mr. Persaud’s decision to resign did not involve any disagreements with the Company, the Company’s management or the Board. On November 11, 2022, the Board of Oxbridge Re Holdings Limited appointed Mr. Dwight Merren, to serve as an independent director on the Board of the Company, effective immediately. Mr. Merren’s appointment was made to fill the vacancy resulting from Mr. Persaud’s resignation, and he was appointed for a term that ends at the 2023 annual meeting of stockholders. Mr. Merren currently serves as an AVP, Private Banking at Butterfield Bank (Cayman) Limited (“Butterfield Cayman”) since December 2021, servicing mainly high net-worth private clientele. Butterfield Cayman is part of the Butterfield Group. Prior to this, from November 2014, Mr. Merren served as a Relationship Manager in Butterfield Cayman’s Corporate Banking Department where he was responsible for the management of a portfolio of corporates across various business sectors, including captive insurers, insurance companies, reinsurance companies, special-purpose vehicles, liquidation accounts, large multinational companies and hedge funds. Mr. Merren previously served as Relationship Manager of HSBC Bank (Cayman) Limited from October 2011 to October 2014, and as Deputy Head – Insurance Division at CIMA, from March 2009 to September 2011. From July 1992 to February 2009, Mr. Merren held senior roles of Administrator at Midland Bank (now HSBC), Assistant Vice President at Willis Management (Cayman) Limited, and Vice President at Global Captive Management Ltd. where he led and managed large portfolio of companies. Mr. Merren served as an independent director at Cayman Islands National Insurance Company, and as the Chairman of the Risk and Compliance Committee, and Chair of the Finance Committee from November 2017 to February 2022. Mr. Merren brings invaluable experience in insurance, banking, risk management, compliance and governance to boards. Mr. Merren was appointed to serve as the Chair of the Compensation Committee, and a member of the Nominating and Corporate Governance, Audit and Underwriting Committees of the Board. Reported Earnings • Nov 18
Third quarter 2022 earnings released: US$0.37 loss per share (vs US$1.14 profit in 3Q 2021) Third quarter 2022 results: US$0.37 loss per share (down from US$1.14 profit in 3Q 2021). Net loss: US$2.16m (down 133% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. Announcement • Nov 09
Oxbridge Re Holdings Limited to Report Q3, 2022 Results on Nov 14, 2022 Oxbridge Re Holdings Limited announced that they will report Q3, 2022 results After-Market on Nov 14, 2022 Reported Earnings • Aug 16
Second quarter 2022 earnings released: EPS: US$0.013 (vs US$0.078 in 2Q 2021) Second quarter 2022 results: EPS: US$0.013 (down from US$0.078 in 2Q 2021). Revenue: US$503.0k (down 38% from 2Q 2021). Net income: US$77.0k (down 83% from 2Q 2021). Profit margin: 15% (down from 56% in 2Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 134% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth. Announcement • Aug 10
Oxbridge Re Holdings Limited to Report Q2, 2022 Results on Aug 15, 2022 Oxbridge Re Holdings Limited announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 15, 2022 Announcement • May 10
Oxbridge Re Holdings Limited to Report Q1, 2022 Results on May 12, 2022 Oxbridge Re Holdings Limited announced that they will report Q1, 2022 results After-Market on May 12, 2022 Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. Independent Director Ray Cabillot was the last director to join the board, commencing their role in 2013. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Apr 06
Insider recently bought US$1.1m worth of stock On the 4th of April, David Lazar bought around 387k shares on-market at roughly US$2.88 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$1.1m more in shares than they have sold in the last 12 months. Reported Earnings • Apr 01
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: US$1.49 (up from US$0.009 loss in FY 2020). Revenue: US$10.2m (up US$9.01m from FY 2020). Net income: US$8.57m (up US$8.62m from FY 2020). Profit margin: 84% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue missed analyst estimates by 6.1%. Earnings per share (EPS) exceeded analyst estimates by 13%. Over the last 3 years on average, earnings per share has increased by 135% per year but the company’s share price has only increased by 61% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorated over the past week After last week's 15% share price decline to US$5.47, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 311% over the past three years. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improved over the past week After last week's 21% share price gain to US$5.73, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 473% over the past three years. Valuation Update With 7 Day Price Move • Dec 31
Investor sentiment deteriorated over the past week After last week's 17% share price decline to US$5.79, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 615% over the past three years. Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment improved over the past week After last week's 19% share price gain to US$5.19, the stock trades at a trailing P/E ratio of 4.1x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 525% over the past three years. Valuation Update With 7 Day Price Move • Nov 19
Investor sentiment improved over the past week After last week's 24% share price gain to US$4.43, the stock trades at a trailing P/E ratio of 3.5x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 310% over the past three years. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS US$1.14 (vs US$0.006 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$7.03m (up US$6.77m from 3Q 2020). Net income: US$6.53m (up US$6.56m from 3Q 2020). Profit margin: 93% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 29
Investor sentiment improved over the past week After last week's 19% share price gain to US$3.56, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 221% over the past three years. Reported Earnings • Aug 18
Second quarter 2021 earnings released: EPS US$0.078 (vs US$0.029 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$805.0k (up 67% from 2Q 2020). Net income: US$448.0k (up 172% from 2Q 2020). Profit margin: 56% (up from 34% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improved over the past week After last week's 19% share price gain to US$4.10, the stock trades at a trailing P/E ratio of 68.7x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 116% over the past three years. Recent Insider Transactions • Jul 15
Insider recently bought US$563k worth of stock On the 9th of July, David Lazar bought around 180k shares on-market at roughly US$3.13 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Announcement • Jul 15
Custodian Ventures Issues a Press Release to Shareholders of Oxbridge Re Holdings On July 13, 2021, Custodian Ventures LLC issued a press release announcing its ownership interest in Oxbridge Re Holdings Limited and desire to work with the Company’s Board of Directors in order to explore potential strategic options for increased shareholder value. Executive Departure • Jul 13
Independent Director Mayur Patel has left the company On the 30th of June, Mayur Patel's tenure as Independent Director ended after 7.8 years in the role. As of March 2021, Mayur still personally held 118.00k shares (US$299k worth at the time). Mayur is the only executive to leave the company over the last 12 months. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improved over the past week After last week's 18% share price gain to US$3.06, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 79% over the past three years. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 24% share price decline to US$2.50, the stock trades at a trailing P/E ratio of 41.9x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 28% over the past three years. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 19% share price gain to US$2.74, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 54% over the past three years. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improved over the past week After last week's 33% share price gain to US$2.63, the stock trades at a trailing P/E ratio of 44.1x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 59% over the past three years. Reported Earnings • May 16
First quarter 2021 earnings released: EPS US$0.005 (vs US$0.063 loss in 1Q 2020) The company reported a soft first quarter result with weaker revenues and profit margins, although earnings were improved. First quarter 2021 results: Revenue: US$319.0k (down 1,487% from 1Q 2020). Net income: US$28.0k (up US$392.0k from 1Q 2020). Profit margin: 8.8% (down from 1,583% in 1Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 31
Full year 2020 earnings released: US$0.009 loss per share (vs US$0.053 loss in FY 2019) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: US$1.21m (up 24% from FY 2019). Net loss: US$50.0k (loss narrowed 84% from FY 2019). Combined ratio: 126.1% (down from 183.3% in FY 2019). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Announcement • Mar 09
Oxbridge Re Holdings Limited to Report Q4, 2020 Results on Mar 30, 2021 Oxbridge Re Holdings Limited announced that they will report Q4, 2020 results After-Market on Mar 30, 2021 Is New 90 Day High Low • Jan 27
New 90-day high: US$3.14 The company is up 71% from its price of US$1.84 on 28 October 2020. The American market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 18% over the same period. Is New 90 Day High Low • Jan 11
New 90-day high: US$2.25 The company is up 6.0% from its price of US$2.12 on 12 October 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 12% over the same period. Reported Earnings • Nov 13
Third quarter 2020 earnings released: US$0.006 loss per share The company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: US$259.0k (down 26% from 3Q 2019). Net loss: US$33.0k (loss widened 120% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Announcement • Nov 08
Oxbridge Re Holdings Limited to Report Q3, 2020 Results on Nov 10, 2020 Oxbridge Re Holdings Limited announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 10, 2020 Is New 90 Day High Low • Sep 25
New 90-day low: US$0.99 The company is down 2.0% from its price of US$1.02 on 26 June 2020. The American market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 3.0% over the same period. Announcement • Aug 06
Oxbridge Re Holdings Limited to Report Q2, 2020 Results on Aug 10, 2020 Oxbridge Re Holdings Limited announced that they will report Q2, 2020 results on Aug 10, 2020 